Intercell USA
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Intercell USA sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Intercell USA: 7 sponsored US clinical trials, none currently recruiting.
Intercell USA sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pandemic Influenza, with 1 trials.
Upper-quartile sponsor footprint
Intercell USA sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch
NCT01067781
A/H5N1/LT Dose Ranging Study
NCT00908687
Traveler's Diarrhea (TD) Automated Process
NCT00751777
LT Vaccine Patch Self-Administration Study
NCT00565461
A/H5N1 Dose Ranging Study With Adjuvant Patch
NCT00532792
Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study
NCT00672035
ETEC Logistics Trial (TREK)
NCT00516659
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 6 |
Therapeutic Areas
How the Intercell USA early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Pandemic Influenza (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Intercell USA: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Intercell USA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Intercell USA page
7 registered trials is a research-attention snapshot, not an endorsement of Intercell USA or any single study.
- None of Intercell USA's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pandemic Influenza is the condition Intercell USA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pandemic Influenza trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Intercell USA pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.